To sift through 6 million molecules in pursuit of new gonorrhea treatments, researchers trained AI to select the best drug ...
Stockhead on MSN
Decidr targets knowledge security as AI’s next phase
The ASX-listed agentic AI company is building AI infrastructure designed to protect company knowledge as an owned asset, as ...
Russian scientists have created a chemical compound that will help patients with Parkinson's disease regain the ability to ...
5don MSNOpinion
Satya Nadella is asking the right AI question
Microsoft’s CEO argues that the future of enterprise AI is not the model, it’s the learning loop. The most important idea in ...
Most AI transformations aim to generate value, not to learn. The most durable advantage comes from designing learning into ...
AI drug discovery cleared its first Phase IIa clinical test in 2025, as BIO 2026 confirmed the shift from speculation to ...
Bigger has defined AI from day one. New data says task-specific small models beat frontier LLMs on accuracy, cost and speed — and save money.
Morning Overview on MSN
A new compound from ETH Zurich cut nerve-cell loss in mice with Alzheimer’s
Scientists at ETH Zurich have identified a compound that sharply reduced nerve-cell death in mice engineered to develop ...
Semiconductor supply chain AI: the U.S. Department of Commerce signed a June 17 CHIPS Act deal giving taxpayers a minority ...
Most people perceive a cork in a bottle of wine as a simple plug meant to keep the liquid in and the outside world out. In ...
Insulin, growth hormone, oxytocin, endorphins and enkephalins are examples of naturally occurring peptides in humans. There ...
Machine learning models narrow down solutions in synthesis, compounding, product design, and more.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results